RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Qualigen Therapeutics Stock

Qualigen Therapeutics ROA 2024

Qualigen Therapeutics ROA

-6.6

Ticker

QLGN

ISIN

US74754R1032

WKN

A2P5C5

In 2024, Qualigen Therapeutics's return on assets (ROA) was -6.6, a 575.47% increase from the -0.98 ROA in the previous year.

Qualigen Therapeutics Aktienanalyse

What does Qualigen Therapeutics do?

Qualigen Therapeutics is a company that specializes in the development and production of innovative therapeutics, diagnostics, and medical devices. It was founded in 1995 and has since become a major player in the bio-pharmaceutical industry. The company focuses on the development of oncology products and has expanded its portfolio to include a wide range of products and services for various disease conditions. It markets its products and services through collaborations with institutions and companies worldwide. The company is divided into different divisions, including oncology, infectious diseases, immunology, and metabolic disorders, each offering innovative products and services tailored to specific clinical needs. In the oncology division, Qualigen Therapeutics develops therapeutics for the treatment of cancer, including a novel lung cancer medication. It has also developed a promising therapy for COVID-19. In the infectious diseases division, the company focuses on the development of diagnostics and therapeutics for the treatment of infectious diseases, such as a rapid HIV test and a novel medication for tuberculosis. The immunology division focuses on the development of diagnostics and therapeutics for autoimmune diseases, including a diagnostic test for rheumatoid arthritis and a novel medication for multiple sclerosis. In the metabolic disorders division, the company develops diagnostics and therapeutics for conditions like diabetes, including a diagnostic test for diabetes and a novel medication for obesity. Qualigen Therapeutics is an innovative and forward-thinking company that specializes in the development and production of therapeutics, diagnostics, and medical devices. It collaborates with various institutions and companies worldwide to market its products and services. Its different divisions offer a wide range of innovative products and services tailored to specific clinical needs. Qualigen Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Qualigen Therapeutics's Return on Assets (ROA)

Qualigen Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Qualigen Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Qualigen Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Qualigen Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Qualigen Therapeutics stock

What is the Return on Assets (ROA) of Qualigen Therapeutics this year?

The Return on Assets (ROA) of Qualigen Therapeutics is -6.6 undefined this year.

What was the ROA of Qualigen Therapeutics compared to the previous year?

The ROA of Qualigen Therapeutics has increased by 575.47% compared to the previous year.

What consequences do high ROA have for investors of Qualigen Therapeutics?

A high ROA is advantageous for investors of Qualigen Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Qualigen Therapeutics?

A low ROA can be unfavorable for investors of Qualigen Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Qualigen Therapeutics affect the company?

An increase in ROA of Qualigen Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Qualigen Therapeutics impact the company?

A reduction in the ROA of Qualigen Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Qualigen Therapeutics?

Some factors that can influence the ROA of Qualigen Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Qualigen Therapeutics important for investors?

The ROA of Qualigen Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Qualigen Therapeutics take to improve ROA?

To improve ROA, Qualigen Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Qualigen Therapeutics pay?

Over the past 12 months, Qualigen Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Qualigen Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Qualigen Therapeutics?

The current dividend yield of Qualigen Therapeutics is .

When does Qualigen Therapeutics pay dividends?

Qualigen Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Qualigen Therapeutics?

Qualigen Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Qualigen Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Qualigen Therapeutics located?

Qualigen Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Qualigen Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Qualigen Therapeutics from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Qualigen Therapeutics pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Qualigen Therapeutics in the year 2023?

In the year 2023, Qualigen Therapeutics distributed 0 USD as dividends.

In which currency does Qualigen Therapeutics pay out the dividend?

The dividends of Qualigen Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Qualigen Therapeutics

Our stock analysis for Qualigen Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qualigen Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.